Study reveals non-statin cholesterol drugs could reduce liver cancer risk
The third leading cause of cancer mortality accounts for over 700,000 deaths every year
Read More
Author: Jen Brogan
Researchers reveal CAR-enhancer therapy could help overcome cancer relapse
Cancer is estimated to affect more than three million people living in the UK, according to Macmillan Cancer Support
Read More
NHS Scotland, AZ and Scottish universities partner for kidney health research
The collaboration aims to develop new medicines to reduce chronic kidney disease in Scotland
Read More
Study finds ovarian cancer-treated women less likely to develop breast cancer
Combined, ovarian and breast cancer affect over 60,000 women in the UK every year
Read More
EPSRC launches two new hubs to transform early disease diagnosis in the UK
Quantum-based technologies will explore infectious diseases, cancer and dementia
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
